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Abstract
Background: Medical terminologies are commonly used in medicine. For instance, to answer a pharmacovigilance
question, pharmacovigilance specialists (PVS) search in a pharmacovigilance database for reports in relation to a given
drug. To do that, they first need to identify all MedDRA terms that might have been used to code an adverse reaction in
the database, but terms may be numerous and difficult to select as they may belong to different parts of the hierarchy. In
previous studies, three tools have been developed to help PVS identify and group all relevant MedDRA terms using three
different approaches: forms, structured query-builder, and icons. Yet, a poor usability of the tools may increase PVS’
workload and reduce their performance. This study aims to evaluate, compare and improve the three tools during two
rounds of formative usability evaluation.
Methods: First, a cognitive walkthrough was performed. Based on the design recommendations obtained from this
evaluation, designers made modifications to their tools to improve usability. Once this re-engineering phase completed,
six PVS took part in a usability test: difficulties, errors and verbalizations during their interaction with the three tools were
collected. Their satisfaction was measured through the System Usability Scale. The design recommendations issued from
the tests were used to adapt the tools.
Results: All tools had usability problems related to the lack of guidance in the graphical user interface (e.g., unintuitive
labels). In two tools, the use of the SNOMED CT to find MedDRA terms hampered their use because French PVS were not
used to it. For the most obvious and common terms, the icons-based interface would appear to be more useful. For the
less frequently used MedDRA terms or those distributed in different parts of the hierarchy, the structured query-builder
would be preferable thanks to its great power and flexibility. The form-based tool seems to be a compromise.
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Conclusion: These evaluations made it possible to identify the strengths of each tool but also their weaknesses to
address them before further evaluation. Next step is to assess the acceptability of tools and the expressiveness of their
results to help identify and group MedDRA terms.
Keywords: Formative evaluation, Usability testing, Cognitive walkthrough, Pharmacovigilance, MedDRA
Background
Medical terminologies are commonly used today in medi-
cine. They are intended to implement semantic interoper-
ability between the various information systems, and to
support search in databases [1]. However, clinicians often
have difficulties to use these terminologies during their
practice [2]. In particular, terminologies may suffer from
synonymy, polysemy, misclassification, poor coverage or,
on the contrary, duplicated terms. The evolution of ter-
minologies also makes them more and more complex, e.g.
with the recent advance in genetics, as terminologies have
to remain backward compatible. Few usability studies have
specifically been focused on the use of medical terminolo-
gies when querying clinical data. A study showed a poor
usability of a compositional interface terminology based
on a subset of SNOMED CT [3]. Moreover, usability
problems found in EHR frequently include terminology-
related issues [4]. A particular case is the use of MedDRA
(Medical Dictionary for Drug Regulatory Activities) by
pharmacovigilance specialists (PVS).
Pharmacovigilance is “the science and activities relating
to the detection, assessment, understanding and preven-
tion of adverse effects or any other drug-related problem”
[5]. PVS supervise and analyze the adverse drug reactions
(ADR) reported by healthcare professionals (e.g., general
practitioners, pharmacists) and patients to healthcare au-
thorities or to the marketing authorization holder. Based
on these spontaneous reports, they collect information on
the reported ADR, the concerned drug, and the patients’
health conditions, contacting afterwards the reporter if
more information is needed. Once all the data is gathered,
a report synthetizing the event is registered into a pharma-
covigilance database using coded terms that closely cap-
ture the original verbatim describing the event. For
international standardization purposes, the International
Council for Harmonization of Technical Requirements of
Pharmaceuticals for Human Use has developed since 1996
a standardized medical terminology thesaurus, MedDRA,
that is nowadays widely used and even mandatory in some
countries for safety reports (e.g., in European Union
countries) [6]. The MedDRA terminology enables to clas-
sify the ADR using a 5-level hierarchy of terms that are
superordinate or subordinate to each other: from the
broadest groups of terms to the more specific, the levels
are System Organ Class (SOC), High-Level Group Terms
(HLGT), High-Level Terms (HLT), Preferred Terms (PT),
and Low-Level Terms (LLT) [7]. Depending on the level
of specificity required, ADR are coded with more or less
specificity using LLT terms.
Besides, PVS are also responsible for answering phar-
macovigilance questions. Those questions may be asked
by physicians, pharmacists or even patients who are wor-
ried about a symptom and wondering whether this
symptom is an adverse reaction to an administered drug.
Patients might also ask for advice on a treatment or on
management of the ADR. To answer those questions,
PVS search information in heterogeneous data sources:
reference books (e.g. Martindale or DRUGDEX®), scien-
tific literature (e.g. querying PubMed), summaries of
product characteristics, and national and international
pharmacovigilance databases (e.g., VigiBase, the WHO
global database, or the French pharmacovigilance data-
base, banque nationale de pharmacovilance - BNPV).
Once the PVS gathers enough information to answer the
question, the spontaneous report associated with the
question is entered and coded in the pharmacovigilance
database. Healthcare authorities may also have demands
regarding signal detection and monitoring (i.e., enhanced
monitoring of a drug to detect a previously unknown re-
lation between an ADR and such a drug). In this case,
PVS will perform a systematic and exhaustive search in
the pharmacovigilance database for all case reports that
were reported in relation to the concerned drug.
When PVS need to identify all reports related to a
given type of ADR, they first need to identify all
MedDRA terms that might have been used to code it in
the pharmacovigilance database. Yet, several problems
related to the coding of the ADR cases and to the struc-
ture of the MedDRA hierarchy hinder identifying and
grouping MedDRA terms.
Coding problems. At the step of entering the case re-
port in the database, the PVS’ profile (i.e. pharmacist or
physician), experience, expertise in the type of ADR, ex-
pertise in MedDRA, and the initial description of the
ADR (i.e., patient’s symptoms, details in the description,
wording), may influence the choice of the MedDRA
terms used to code the ADR. As a result, different Med-
DRA terms might be used to code the same ADR. For
instance, “purpura” is a small hemorrhage of the skin,
but also mucous membrane which may be caused by
various factors. The term “purpura” or “ecchymoses” can
be coded with very various terms some of which may
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pose problems of choice or diagnosis (ex. “purpuric
rash”, “rash hemorrhagic”, “purpura symptomatica”,
“Henoch-Schönlein”, “allergic vascular purpura”).
MedDRA structure problems. Brown has described in
2003 several pitfalls that make it difficult to search case
reports in pharmacovigilance databases with MedDRA
[8]. Further evolutions of MedDRA have attempted, and
in some cases succeeded, to lower such difficulties. Yet,
terms representing a same medical condition may be
scattered all over the MedDRA hierarchy, belonging to
different SOC at different levels [9]. The MedDRA struc-
ture still makes it difficult to build custom groupings of
MedDRA terms that are representative of a medical con-
dition. For example (Fig. 1), when searching case reports
of “Myocardial infarction” it is relevant to include terms
that describe clinical conditions such as “Coronary artery
embolism” but also results of investigations such as
“Troponin T increased”. However, investigations are not
linked to the corresponding medical conditions in
MedDRA which does not enable to perform such associ-
ation in an automated way. Besides, the structure of
MedDRA does not systematically allow selecting a single
category where all terms relevant to a given medical
condition would be present excluding others. This is the
case for “Myocardial infarction”. The HLGT “Coronary
artery disorders” contains some relevant terms such as
“Coronary artery embolism” or “Myocardial infarction”
but also non relevant terms such as “Diabetic coronary
microangiopathy” or “Chest discomfort”. The HLT
“Skeletal and cardiac muscle analyses” includes the PT
“Troponin T increased” that is evocative of myocardial
infarction while the PT “Aldolase normal” is not. Be-
sides, there is no intersection between “Troponin T in-
creased” and “Electrocardiogram ST segment elevation”
below SOC Investigations. It would therefore be useful
for MedDRA to propose a greater number of groupings
that would contain only the terms relevant to that
grouping. However, in a given SOC, a PT can only be-
long to one HLGT. Thus, it is not possible to constitute
in the same SOC several HLGT groups containing the
same PT [8].
The current solution to these problems is to build
Standardized MedDRA Queries (SMQ) that group PTs
from different SOC, HLGT and HLT [10]. A SMQ is
available for MedDRA users, but the number of SMQ is
still insufficient to cover every need when querying a
pharmacovigilance database, and new means to support
building such groupings in a more automated way are
desirable.
Tools linking ADR and MedDRA terms could help PVS
in this task. This article presents the formative evaluations
of three tools developed for this purpose in the PEGASE
(Pharmacovigilance Enrichie par des Groupements
Améliorant la détection des Signaux Émergents - in
English, improved pharmacovigilance and signal detection
with groupings) project. This project is a project funded
by the French national research agency, and its goals are
to develop usable tools to help PVS finding all relevant
MedDRA terms that might have been used to code a given
ADR, and to ensure searches achieve a good
completeness.
Study context: the PEGASE project
A semantic resource, OntoADR, that described MedDRA
terms with semantic relations has been developed based
on the SNOMED CT ontology during a former European
project [12]. Instead of searching one by one all terms in
the MedDRA terminology, PVS can search groupings of
terms using semantic relations such as “hasFindingSite” to
describe the anatomical site concerned by the ADR, or
“hasAssociatedMorphology” to describe the abnormal
morphologies related to the ADR (see Fig. 2). This way,
Fig. 1 Illustration of the heterogeneity of the MedDRA categories used to code the ADR “Myocardial infarction”. Relevant PT (green circle) are
found in two SOC (“investigations” and “cardiac disorders”). Some HLT categories contain both relevant and irrelevant (red circle) terms
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PVS could identify and group all relevant MedDRA terms
related to a given change on/in a site. Currently, 67% of
MedDRA’s PTs are described with at least one defining re-
lationship with SNOMED CT [12].
MedDRA and OntoADR have been made available to
PVS through two tools based on different interaction
modes: OntoADR query tool (OQT) whose interaction
is based on forms, and Sparklis, based on guided query
building in natural language. A third tool, Mister VCM
(MVCM), based on an iconic language, links ADR dir-
ectly to MedDRA terms without relying on OntoADR.
The ultimate goal of the PEGASE project is to identify
the tool that best reconciles usability (“the extent to
which a product can be used by specified users to
achieve specified goals with effectiveness, efficiency, and
satisfaction in a specified context of use.” [13]) and ex-
pressiveness (the quantity and type of questions the sys-
tem can answer [14]).
However, the literature on the usability of health tech-
nologies, whether information technologies or medical
devices, shows that poor usability hinders their use, pre-
vents users from taking full advantage of them and can
bias the assessment of their impact. Indeed, the presence
of usability problems (e.g. navigation problems, display
fragmentation) increases users’ cognitive workload. Med-
ical terminology-based interfaces are also affected by
these usability problems [3]. As a result, users spend
their cognitive and attentional capacities to navigate,
find and retain information, leaving them with few cog-
nitive and attentional resources to perform their main
tasks [15]. In particular, expert activities such as
pharmacovigilance case-finding require the cognitive
and attentional abilities of PVS to be fully available, let-
ting PVS concentrate and reason about solving the prob-
lems they face: if cognitive and attentional capacities are
taken up by solving navigation or information gathering
problems, they are less available for the actual pharma-
covigilance task, and user performance is reduced. On
the contrary, an improvement in the usability of a tech-
nology is associated with a lower cognitive load and an
improved performance [16].
As the usability of the PEGASE tools is likely to affect
their acceptability [17] and their performance, it is ne-
cessary to evaluate and improve their usability before re-
leasing them and evaluating their impact. This is the
purpose of formative usability evaluations reported in
this paper.
Objective
The purpose of this study is to evaluate, compare and
improve, as much as possible, three interfaces using dif-
ferent approaches for facilitating the use of MedDRA by
PVS: forms, structured query-builder and icons. The
study relies on two rounds of formative usability evalua-
tions for identifying the usability problems of each inter-
face. This evaluation has no preliminary intention to
make the three tools converge towards an identical, po-
tentially ideal mode of interaction.
Development and description of the tools
One of the main characteristics of the PEGASE project
is that it strictly follows a user-centered design process,
Fig. 2 Comparison between methods to search in the MedDRA terminology (adapted from [11] with permission). Left, usual method: string
search and hierarchy search. Right, search through semantic relations made possible by OntoADR (semantic query)
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in which the needs and the characteristics of the end-
users and the usability of the tools under development
are the focus of the design activities at each step of the
design process [13]. Following the recommendations of
the user-centered design approach, the design process
started with a review of scientific papers addressing the
usability of keywords search technologies and with a
cognitive work analysis of the PVS strategies to search
for MedDRA terms [18]. The results of this first phase
were used to adapt the three tools as far as possible to
the context of the MedDRA terms search by PVS. The
following subsections describe the three tools as they
were before their formative usability evaluations.
OntoADR query tool
OntoADR Query tool (OQT) is a web-based interface to
query OntoADR semantic resource [11]. It uses forms to
support the creation of queries based on properties ex-
tracted from SNOMED CT semantic relationships. Users
can choose properties to be included in or excluded
from their queries using a tree representing SNOMED
hierarchy or using keyword-based search. The tool up-
dates the query automatically for the addition or sup-
pression of the selected terms. The MedDRA terms
resulting from the constructed query are presented in a
selectable list from which users can choose terms to ex-
port or to search case reports in a subset of FAERS
(FDA Adverse Event Reporting System).
Sparklis
Sparklis [19] is a query builder in natural language that
allows people to explore and query semantic databases
without any knowledge of the Semantic Web technolo-
gies (RDF, SPARQL) [20]. Sparklis is implemented as a
Web client running entirely in the browser, which dir-
ectly connects to a semantic database to retrieve query
results and suggest query elements. It covers a large sub-
set of the SPARQL 1.1 query language, including com-
plex graph patterns and complex expressions. All query
features can be combined in a flexible way. Results are
presented as tables. A configuration panel offers a few
configuration options to adapt to different databases.
Sparklis reconciles expressivity and usability in seman-
tic search by tightly combining a Query Builder, a
Natural Language Interface, and a Faceted Search sys-
tem. As a Query Builder, it lets users build complex
queries by composing elementary queries in an incre-
mental fashion. An elementary query can be a class (e.g.,
“a film”), a property (e.g., “that has a director”), an entity
(e.g., “Tim Burton”), a reference to another entity (e.g.,
“the film”), or an operator (e.g., “not”, “or”, “highest-to-
lowest”, “+”, “average”).
As a Faceted Search system [21], at every step, the
query under construction is well-formed, query results
are computed and displayed, and the suggested query el-
ements are derived from actual data - not only from
schema - so as to prevent the construction of non-
sensical queries or empty results. The display of results
and data-relevant suggestions at every step provides con-
stant and accurate feedback to users during the con-
struction process. This supports exploratory search,
serendipity, and confidence about final results [22].
As a Natural Language Interface, everything presented
to users - queries, suggested query elements, and results
- are verbalized in natural language, completely hiding
SPARQL behind the user interface. Compared to Query
Answering (QA) systems [23], the hard problem of
spontaneous natural language understanding is avoided
by controlling query formulation through guided query
construction, and replaced by the simpler problem of
natural language generation. The user interface lends it-
self to multilingualism, and is so far available in English,
French, and Spanish.
As Sparklis is so generic, it required some data prepar-
ation and adaptations in order to be applied in the
PEGASE project [24]. First, a semantic database was
built by integrating the MedDRA terminology, the
OntoADR and SNOMED ontologies, and patient data
from FAERS. Second, Sparklis was extended to cope
with the term hierarchies found in MedDRA and
SNOMED. The latter introduces some complexity that
may hinder the responsiveness of Sparklis, depending on
the performance of the database server.
MVCM
The MVCM tool [25] focuses on the use of the VCM
iconic language for browsing MedDRA. VCM [26] is an
iconic language for representing the patient main clinical
conditions, including symptoms, diseases, physiological
states (e.g. age class or pregnancy), risks and history of
diseases, drug and non-drug treatments, lab tests and
follow-up procedures. It includes a set of visual primi-
tives (5 colors and 150 pictograms) and a simple gram-
mar to combine these elements and create thousands of
icons.
For representing clinical signs and disorders, a VCM
icon is made of a color, a basic shape, a central picto-
gram and a set of modifier pictograms. The color indi-
cates the temporal aspect of the icon: red for current
states of the patient, orange for risk of future states, and
brown for past states. The basic shape is a circle for
physiological states or a square for pathological states
(diseases and symptoms). The central pictogram indi-
cates the anatomico-functional location (e.g. endocrine
system) or the patient characteristic (e.g. pregnancy) in-
volved; and special pictograms are available for the main
specific disorders associated with a specific anatomico-
functional location (e.g. diabetes for endocrine system).
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Modifier pictograms can be added to specify (a) a gen-
eral pathological process (e.g. tumor, infection), and (b)
a “transversal” anatomical structure that can be present
in many anatomico-functional locations (e.g. blood ves-
sels and nerves are present in most organs).
The mapping between MedDRA terms and VCM
icons was achieved using the VCM ontology [27], which
formalizes the semantics of VCM icons.
MVCM [26] is a schematic anatomical sketch that
shows the 37 most generic VCM pictograms, grouped in
6 regions: the head, the hat (for social medicine), the
thoughts (for psychology and addictions), the trunk, the
arm (only one limb is detailed) and the etiologies (out-
side the body).
The MVCM interface for searching pharmacovigi-
lance database is split in two parts (see an example in
Fig. 6): the left part offers various methods for query-
ing, and the right part displays the results. Three
methods are proposed for searching: (a) full-text
search by entering keywords, (b) iconic search by
clicking a pictogram on MVCM, and (c) hierarchical
selection by choosing the desired depth level in Med-
DRA using checkboxes. The three methods can be
used independently or in combination, in any order.
It also allows to select drugs and to start the search
in the pharmacovigilance database.
The MedDRA terms found are grouped by VCM icons
in small panels, each displaying at most five terms. The
entire list of terms can be obtained by clicking on the
panel. Moreover, the user can click on a term to display
its parents and children, allowing a hierarchical naviga-
tion in MedDRA.
Methods
Following the user-centered design process recommen-
dations, the formative usability evaluations of the tools
were performed in an iterative manner [13] with two
rounds. First, a cognitive walkthrough (CW) was per-
formed. Based on the design recommendations from this
evaluation, the designers made modifications to their
tools to improve usability and make them better fit to
the needs of the PVS. Second, once this re-engineering
phase was completed, usability testing was organized.
CW is a method developed to evaluate how easily a
tool can be handled [28]. It focuses on the learnability of
the tool for untrained or uncommon users. The CW
proceeds through the analysis by experts in human fac-
tors of the mental processes required by users during
the interaction with a tool [29]. It aims at identifying the
design aspects of the system that may perturb the inter-
action of the user or even prevent her from using the
tool.
Usability testing consists in observing representative
end-users interacting with the technology under-
evaluation to perform tasks [30, 31]. During the evalu-
ation, users are commonly asked to “think-aloud” while
interacting with the tool to get insights on their cogni-
tive processes during the interaction. The analysis of be-
haviors and verbalizations of the participants enables to
identify the problems they encountered with the tech-
nology and the usability defects that are behind [30].
Both methods have their own advantages and draw-
backs. The literature recommends using these two
methods together to improve the detection of usability
problems [32]. Methods and results are presented as far
as possible in accordance with reporting guidelines in
the field [33].
Formative cognitive walkthrough
Two researchers in human factors (LD and RM) con-
ducted the CW. For each tool, the researchers first
determined the sequence of tasks a user is intended
to perform with the tool. Then, they examined the
graphical user interface (GUI) state, before and after
each action of the sequence of tasks, to assess
whether PVS would succeed in performing the appro-
priate action at each point of the sequence. To do so,
they asked systematically 4 questions at each step of
the sequence [29]:
 Will the user be trying to achieve the right effect?
 Will the user notice that the correct action is
available?
 Will the user associate the correct action with the
desired effect?
 If the correct action is performed, will the user see
that progress is being made?
The two researchers discussed each question until a
consensus on the answer was reached. Each time a ques-
tion was answered negatively at a point of the sequence
of action, the reason was noted, the usability defect be-
hind was searched and categorized according to usability
heuristics [34], and a recommendation was proposed to
fix this usability defect.
At the time of this evaluation, MVCM was not fully
developed for pharmacovigilance. Thus, the CW was
performed on screenshots of the different steps of the
sequence of tasks. Descriptions given by the developer
enabled to understand the GUI and the behavior of the
tool at each point of the sequence.
The results were given to the designers of each tool
along with videos of mock-ups illustrating recommenda-
tions for improvement. Then, designers analyzed those
results to correct issues that may have affected the us-
ability of the system and made the changes that were
technically possible.
Marcilly et al. BMC Medical Informatics and Decision Making          (2020) 20:261 Page 6 of 15
Formative usability testing
Once the three tools have been redesigned, a second
round of evaluation was carried out with usability test-
ing. Tests were performed individually on the French
version of the tools (the GUI and the relations were in
French; only the SNOMED CT terms were in English).
Figure 3 represents the organization of a test session.
After a short introduction to the PEGASE project and
signature of consents, participants tested each tool suc-
cessively. The running order of the tools’ tests was offset
to prevent learning effects (Table 1).
For each tool, the participants were first introduced to
the SNOMED CT terminology (its purpose, philosophy,
and organization) with a focus on the semantic relations,
and to the tool to evaluate (philosophy, use instructions,
and descriptions of the main features). Then, a question
to a PVS, randomly attributed, was given to each partici-
pant as both written text and verbal description. The
questions were inspired from actual case reports in the
scientific literature selected by a PVS to represent ques-
tions that pharmacovigilance centers may receive. These
cases should not be too frequent or too obvious (i.e., not
containing the corresponding MedDRA terms in their
title or description) for the PVS to be unfamiliar with
the MedDRA terms to be used and search for them
using the tools. Moreover, since only 67% of the PTs are
described with at least one defining relationship with
SNOMED CT [12], it was important to check before-
hand that the target terms for the cases were mapped to
at least a minimal set of SNOMED CT concepts. The
final 6 questions targeted were: (1) hearing disorder [35],
(2) acute kidney injury [36], (3) progressive multifocal
leukoencephalopathy [37], (4) glycemic dysregulation
[38], (5) leukocytoclastic vasculitis [39], and (6) glau-
coma [40]. In this way, these cases make it possible to
test the main functions of the three tools.
Each participant was asked to use the tool to find case
reports that may help answer the question and to think-
aloud all along the interaction. In case of difficulty in
finding a SNOMED term due to a lack of knowledge of
English terms, participants were asked to express the
searched term in French and the experimenter gave
them the English version. Once the participants consid-
ered that they had found the case reports, they were
asked to complete the System Usability Scale (SUS [41]).
Each tool’s test ended with a debriefing on the inter-
action with the tool to deeply understand the partici-
pants’ behavior, and to get their opinion on the
advantages, drawbacks and usefulness of the tool.
A total of 6 PVS were recruited. This sample size is in
line with the recommendations from the literature and
standards in the field (5 to 8 per user profile [42, 43]): 6
participants enable to detect more than 85% of the tools’
usability defects.
The tests were performed in the office of the PVS.
During the tests, a human factors researcher sat further
back the participants to observe their behavior. Data col-
lected included the hesitations, misunderstandings, diffi-
culties and usage errors along with the usability defects
behind them, and participants’ verbalizations. Data were
analyzed independently for each tool, to identify room
for improving the usability. The tests were audio and
video recorded.
Results
The three tools do not have the same level of functional-
ity and complexity. Therefore, they should not be com-
pared based on the number of usability problems
detected.
OntoADR query tool
The results of the two rounds of usability evaluation are
presented in Additional file 1: Appendix 1 along with
the resulting suggestions for improvement. A total of 12
usability defects were uncovered with the CW. During
the reengineering phase, either suggestions for fixing
nine defects have been (partially) followed (nine cases),
or the concerned feature has been removed. Usability
Fig. 3 Overall organization of the usability tests. Time is expressed in hours and minutes
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tests uncovered nine problems: three ones were already
detected by the CW, three ones which were not detected
during the CW, and the three last ones concerning some
new features.
The biggest issues concerned the use of SNOMED CT
as PVS did not know this terminology. Indeed,
SNOMED CT is very different from MedDRA. Even
with training before the usability test, PVS did not
understand its intrinsic logic and how to use it, thus
using SNOMED CT was difficult for the participating
PVS. Those issues with SNOMED CT were amplified by
the fact that the SNOMED CT terminology was in Eng-
lish, by the long lists of (sometimes look-alike) items
proposed in the editable drop-down menus and by the
absence of organization of these items. During the us-
ability test, human factors experts had to help PVS
choose the right SNOMED CT relation or term to use.
Another important set of usability problems was re-
lated to the building of the query: in the first version of
OQT, the visual organization of the page did not fit the
cognitive processes underlying information search (steps
were organized from right to left while information
search proceeds from left to right), the use of the Bool-
ean connectors was not explicit to the users, and several
modes to build different types of queries co-existed on
the GUI. Almost all the problems related to the query
building disappeared after the reengineering.
Despite remaining usability problems, during the us-
ability test, participants perceived the interaction with
OQT as easy, as it was reflected by the 57 score on
the SUS scale (“ok” tool according to [44]), and by
positive comments on its ease of use to build a query.
Due to the use of the SNOMED CT to build a query,
participants found the query building process to
search case reports too complex. This may be in part
explained by the GUI and SNOMED CT being re-
spectively in French and English, and SNOMED CT
terms having a form that does not look like medical
terms. Finally, participants regretted not being able to
explore the MedDRA hierarchy into this tool to en-
sure that all relevant MedDRA terms were selected.
Consequently, it was suggested to facilitate the use of
the SNOMED CT to search and group MedDRA
terms, especially by replacing those terms by actual
medical terms and their synonyms in French. Without
this evolution, it is unlikely the tool would prove to
be used and useful.
The results of the usability testing were used by the
developers to improve the OQT. The new version of the
GUI is depicted in Fig. 4.
Sparklis
The results of the two rounds of Sparklis evaluation are
presented in Additional file 1: Appendix 2 with sugges-
tions for improvement. A total of 14 usability problems
were detected with the CW. Four problems identified
through the CW could not be tested during the usability
test session: due to test time limitations, very simple
queries were used preventing from using some func-
tions. The usability tests identified nine problems of
which five had already been detected by the CW, and
four new ones. It should be noted that technical prob-
lems (very long response time of Sparklis) strongly dis-
turbed five of the six usability tests.
As for OQT, one of the main problems detected
comes from the use of SNOMED CT semantic relations
that PVS are not familiar with and from the use of the
English SNOMED CT terminology which makes it more
difficult to find the relevant terms. It was therefore rec-
ommended to make the use of SNOMED CT semantic
relations invisible and to consider the use of a French
version of the terminology.
Nevertheless, the main problem of Sparklis is re-
lated to the mode of interaction to build a query: it is
very different from the mode the PVS are currently
used to (e.g. in the BNPV). For example, the change
of focus to build the query is not immediately under-
stood by all users despite training. The same problem
applies to the distribution of item categories and lists
of terms in different menus. The lack of user guid-
ance to know which menu to use hinders or even
blocks users. Another problem is that Sparklis is a
very general, powerful, tool that allows to formulate a
very wide range of query structures: the task under
evaluation is only one kind of the many possible
searches. Yet, PVS usually perform a small number of
Table 1 Order of the tools for each participant and question of pharmacovigilance answered at each test
Sparklis PV question M. VCM PV question OQT PV question
P1 A 3 B 6 C 1
P2 A 5 C 1 B 6
P3 B 2 A 3 C 5
P4 B 3 C 2 A 4
P5 C 2 A 5 B 3
P6 C 5 B 6 A 2
Letters (A, B, C) represent the order of the tools tested for each participant, the number (1 to 6), the question of pharmacovigilance answered at each test
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query structures; therefore, they can get easily lost in
the different possibilities. It is necessary that the ver-
sion of Sparklis for PVS offers only the necessary and
sufficient items to perform daily PV queries, with an
expert mode that allows more possibilities for com-
plex case reports. This option has already been par-
tially integrated following the CW with the creation
of different expert modes, but the novice mode needs
to be further simplified to be used by beginners.
More intensive training is needed to enable PVS to
use Sparklis efficiently.
In terms of user experience, at first glance, participants
were disturbed by the appearance of Sparklis, it seemed
for them “difficult to use” and “complex”. However, after
training, the participants said that they generally under-
stood the principle of use, even though they believed
they needed more explanation and training to use it cor-
rectly. This tool has been preferred by some participants
in particular because its flexibility allows to make differ-
ent types of requests, simple and complex, via MedDRA
or SNOMED CT terms. Even if this flexibility makes it
difficult for novice users to use the tool, it also increases
its potential usefulness for current pharmacovigilance
practice. The average SUS score of 43 (poor satisfaction
[44]) at the end of usability tests seems to reflect mainly
the annoyance of users due to Sparklis slowing down
during the tests, and not an actual dissatisfaction regard-
ing its functionality.
Fig. 4 Screenshot of the OQT tool (version 2). The left frame contains the fields and trees needed to search properties for the
construction of a query, the middle frame shows automatically the query being constructed and the right frame shows the MedDRA
terms found for the current query. This last frame contains buttons allowing the user to select or deselect all terms, export selected
terms or use them to search case reports in FAERS
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The results of the usability testing were used by the
developers to improve the tool. The new version of the
GUI is depicted in Fig. 5.1
MVCM
The results of the two MVCM evaluation rounds are
presented in Additional file 1: Appendix 3 along with
suggestions for improvement. A total of five usability
problems were detected with the CW; they were cor-
rected during the re-engineering phase. The usability
tests identified nine other problems.
MVCM generally follows the way PVS search for key-
words. However, problems with the guidance and signifi-
cance of the terms used can hamper users and impair
search efficiency: some information and interface
interaction elements are not sufficiently visible (e.g., “ back
“, “ text search “, “ tooltips “) or intuitive (“ combination of
several icons “, “ selection of level in the hierarchy “, “ add-
ing a term to the query “).
In terms of their experience, participants found MCVM
“fun” and “simple”. Participants who were resistant to the
tool when MCVM was first presented, appreciated
MCVM after use. According to the PVS, this tool would
be most useful for people with little knowledge of pharma-
covigilance to allow them to deal with simple case reports.
Its usefulness would be more limited once the MedDRA
terms are known or when ADR are not anatomically local-
ized or are very specific (e.g., Progressive multifocal leu-
koencephalopathy). The SUS score of 72 (“good” [44])
shows a good level of satisfaction with this tool.
The results of the usability testing were used by the
developers to improve the tool. The new version of the
GUI is depicted in Figs. 6 and 7.
Fig. 5 Screenshot of Sparklis on PEGASE data illustrating the process of building a query (version 2019–05). The current query (at the top)
selects PT in MedDRA whose finding site is “Skin and subcutaneous tissue structure”, and whose associated morphology is various
morphologic abnormalities. A first abnormality, “Blister”, has already been selected, and the user is in the process of selecting (at the
center) a disjunction of three more abnormalities (“Vesicle”, “Vesiculobullous rash”, “Vesicular rash”). The keyword “vesic” was input at the
top of the list of suggested terms in order to ease their retrieval among a long list of suggestions. Sparklis suggests changes to be
applied to the current focus (here, the focus is on the associated morphology of the selected PT): at the middle left, Sparklis suggests
types and relations to refine the query; at the middle center, terms denoting associated morphologies relevant to the query; and at the
middle right, query modifiers and operators (e.g., “and”, “or”). The table of results of the current query is shown at each step. Here, it
shows the selected PT along with their finding sites and associated morphologies
1A screencast of the whole query building is available at http://www.
irisa.fr/LIS/common/documents/pegase2018/#ExtraCase
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Discussion
Principal results
The present study aimed to evaluate, compare and im-
prove the usability of three tools developed to help PVS
identify and group all relevant MedDRA terms using
three different approaches: forms, structured query-
builder, and icons. Two rounds of formative usability
evaluation were performed: first with a CW, and then
with a usability testing. A reengineering phase took place
between both evaluation phases to improve the usability
of the three tools.
All tools had usability problems during the first round
of CW evaluations. Some problems were not resolved
during the re-engineering phase either because usability
testing was desirable to confirm them, or because these
problems required too extensive modifications to the
tools (by affecting the underlying philosophy of the tool),
or because technical limitations did not allow the prob-
lem to be resolved. Other problems arose in the second
round of evaluations because the interface had been
modified (e.g., adding features) or because these prob-
lems were only detectable by observing real users inter-
acting with the tools [32]. It should be noted that some
problems detected with the CW method were not de-
tected with the usability testing although they had not
been corrected: these usability problems did not really
bother users when interacting with the tools and can be
considered as false positives which diminish the validity
of the results (defined by Sears (1997) as a “focus on is-
sues that are relevant” [45]) of the CW. Applying two
Fig. 6 Screenshot of MVCM GUI (version 2.4). The screenshot presents the state of the GUI after searching for “urinary tract” (with VCM
pictogram) and “chronic conditions” (with lexical keyword)
Fig. 7 Screenshot of MCVM’s keyword search feature (version 2.4). The
screenshot presents both textual keywords (in black) and semantic
concepts from SNOMED CT (with the name of the relationship in blue)
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complementary usability assessment methods allows for
the weighting of the importance of the problems de-
tected: those that really bother users should be ad-
dressed first.
The three tools cannot be compared in terms of the
number of problems detected because they have differ-
ent levels of complexity. Nevertheless, it is possible from
a qualitative point of view to identify types of problems
that were found in several tools.
First of all, although using SNOMED CT to find and
group MedDRA terms seemed a promising idea when
the PEGASE project started, the evaluations showed that
the requirement that the user needs to understand this
resource was an important limitation for Sparklis and
OQT. Indeed, the French PVS are not familiar with
SNOMED CT and its structure, and the short training
did not allow them to understand and acquire the
needed experience for the efficient use of semantic rela-
tions. On the contrary, MVCM does not rely on
SNOMED CT for interactions with users and was well
perceived by test participants. This suggests that inter-
acting with SNOMED CT (e.g., using the appropriate se-
mantic relation) might be the origin of the problem as it
has been already pointed out [46]. Sparklis and OQT
have to find a solution for improving interactions with
SNOMED CT. One possible solution to overcome this
problem would be to train and coach PVS more inten-
sively to use SNOMED CT. However, even if training
would allow PVS to master the main categories, it would
not allow them to master the entire ontology (352,567
concepts [47]). As one PVS noted during a usability test,
having to learn SNOMED CT, “just shifted the problem”
from a lack of knowledge of MedDRA terminology as
more training on MedDRA terminology would be more
appreciated. The optimal solution would be to “hide” the
use of semantic relations and SNOMED CT ontology
from the PVS so that they benefit of their advantages
without having to learn them. This solution requires de-
velopers to thoroughly rework how the tools work and
can be a lengthy task. However, this “invisibility” of the
interaction with SNOMED CT would certainly be appre-
ciated by the PVS; indeed, the MVCM tool that does not
show semantic relations of SNOMED CT has been ap-
preciated for its simplicity.
The use of item lists to perform queries by OQT and
SPARKLIS was also problematic because of the length of
the lists and their non-intuitive organization for the
PVS. This usability problem is frequently found in health
information technologies [48] and also in terminology-
based interfaces [4]. Even if this problem seems simple
to solve, it nevertheless requires a reflection on the items
to be kept in the lists, which may also question the way
to carry out the queries. Indeed, the calibration of the
lists is necessarily done according to the profile of the
users, but novices and experts have different needs to
perform a query; lists calibrated for a single profile
would make the tools useless for the other profiles.
The other noteworthy usability problems were related
to the GUI that were not guiding enough, i.e., their
organization and the icons and labels used did not al-
ways sufficiently inform participants about what they
could do and how. These usability problems are also
commonly found in health technologies [48, 49] and in
terminology-based interfaces [3, 4, 50–53]. To be cor-
rected, these problems require work to reformulate in-
formation on labels and buttons, which only requires
modifying the interface, not the tool in-depth, and can
be done quickly.
Even if the three tools cannot be quantitatively com-
pared in terms of usability, feedback from participants
during the tests made it possible to identify the per-
ceived advantages and disadvantages of each tool (see
Table 2). In fact, the perceived usefulness of the tools
depends on the complexity of the MedDRA term search.
For the most obvious and common terms to be found,
the MVCM tool, the icon-based interface, would appear
to be more useful due to its ease of use. On the contrary,
for the less frequently used MedDRA terms or those dis-
tributed in several SOC, Sparklis, the structured query-
builder based on natural language, would seem to be
preferable thanks to its great power and flexibility, the
latter having proven their usefulness in other domains
[19]. OQT, the form-based interface, would seem to be a
good compromise between both tools. However, the ne-
cessary knowledge of the SNOMED CT logic could pre-
vent the routine use of Sparklis and OQT by PVS who
are not experts in this terminology.
Strengths and limitations of the formative evaluations
performed
Although many studies have focused on software based
on standardized terminologies, few have actually evalu-
ated the usability of these technologies to improve it [3,
4, 50–53]. In the context of the use of MedDRA termin-
ology, to our knowledge only one study has evaluated its
usability ([11] on OQT). However, in this study the us-
ability evaluation was only carried out subjectively using
the SUS questionnaire; even if the latter enables to as-
sess the level of satisfaction of the participants, it does
not help in understanding what the users liked or dis-
liked, and what features of the tools may have disturbed
the performance of their tasks. The present study pro-
vides data to improve user interaction by concretely
evaluating and comparing the usability of three different
types of tools allowing the exploration of a medical
terminology.
The main strength of the study is that it has com-
bined two different methods in order to overcome the
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shortcomings of each of them. The CW on the first
versions of the tools allowed to detect so-called com-
mon problems in usability, guidance and intuitiveness.
Then, the usability testing allowed to detect usability
problems linked to the mismatch between the work
models implemented in the tools, and the tasks actu-
ally performed by the PVS [32]. In addition, iteratively
performing two evaluation rounds also made it pos-
sible to detect new usability problems caused by
interface modifications.
Furthermore, for the evaluation of MVCM, usability
testing compensated for the potential weakness of the
CW performed on screenshots by detecting problems
that the CW may not have allowed to be identified.
Several points may have affected the completeness
of the problems detected. Due to the slowdown of
Sparklis, the behavior of the PVS may not have been
natural and some problems that would have emerged
in real life may not have been detected. During the
tests, participants interacted with an interface and re-
lationships in French while the terms to be used were
in English. Constantly switching from French to
English may have hindered their interactions with the
tools, also hindering the detection of potential prob-
lems. Furthermore, in order not to extend the dur-
ation of the tests (that were approximately 1 h30
long), it was chosen not to test some secondary func-
tions but to concentrate the evaluation on the main
functions for which usability problems could hinder
or block users. It is more important to detect prob-
lems that limit optimal use and that will deteriorate
user performance rather than to draw up an exhaust-
ive list of all problems, even those very rarely en-
countered and with no impact. Users were only able
to make two or three queries per tool, which limited
appropriation.
The target terms of the cases used during the tests
should be mapped to at least a minimal set of SNOMED
CT concepts. Yet, there were still deficiencies in some
definitions of MedDRA terms in OntoADR. This kind of
deficiency would have impacted studies on the com-
pleteness of the underlying knowledge representation of
MedDRA terms. The present study focused on the us-
ability of the GUI of the tools. It is unlikely that those
deficiencies in the mapping had consequences for users
and influenced the results of the evaluation. Nonetheless
it would make it worse if new examples with no available
SNOMED CT definition were selected in future work.
This is the reason why improving completeness of defi-
nitions in OntoADR is important to guarantee perfor-
mances in real life that are close to performances we
observed in constrained laboratory environment.
Future work
The corrections related to usability problems that were
feasible during the period of the project while respecting
the mode of interaction of the tools were performed.
The next step consists in comparing the expressiveness
of the output of the three tools as well as their accept-
ability during an in-situ evaluation. This way, the tools
can be really compared on their mode of interaction,
their expressiveness and their perceived usefulness. The
perspectives of this work also include the adaptation of
the three tools to other medical terminologies, e.g. for
supporting the coding of electronic health records.
In addition to the context of answering questions from
healthcare professionals, OntoADR could be useful in
pharmacovigilance to analyze with natural language pro-
cessing textual resources such as comments associated
with some case reports, or to perform automated signal
detection. In a separate study, we performed some tests
on signal detection. Although it is possible to increase
the number of detected signals by grouping terms with
[54] or without [55] an ontology compared to perform-
ing signal detection with single PTs, we observed that
grouping does not necessarily allow to detect these sig-
nals earlier and had to figure in which situations group-
ing may expedite signal detection. We assume that
groupings in our experiments consisted of too large
number of terms which was not appropriate: focusing
Table 2 Synthetic list of advantages and drawbacks of the three tools under evaluation
OQT (forms) Sparklis (natural language) MVCM (iconic language)
Advantages • Quickly shows the results
of term searches
• Easy to use
• Powerful tool adapted to different
kind of practices
• Single page for the query and
case analysis which facilitates the
refinement of the query
• Intuitive and “playful”, visual
iconic language
• Sense of familiarity: no need
to go through SNOMED CT
• Possibility to navigate in the
MedDRA hierarchy
Drawbacks • Requires knowledge of
SNOMED CT logic
• Requires knowledge of
the right SNOMED terms
and their hierarchy
• Not possible to search/
navigate in the MedDRA hierarchy
• Requires knowledge of SNOMED
CT logic
• Requires knowledge of the right
SNOMED terms and their hierarchy
• Requires practice to fully understand
how to use the tool
• Limited in possible searches
• Not suitable for expert PVS
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on smaller sets of MedDRA terms could lead to better
results. Further studies need to be conducted to test this
hypothesis.
Conclusion
Three tools with different kinds of interface have been
developed or adapted to help PVS find MedDRA terms
and group them together to perform pharmacovigilance
queries. In order to improve the usability of the tools as
much as possible, two iterations of formative evaluations
have been carried out through CW and usability testing.
These two methods proved to be complementary by de-
tecting different problems. The results of these two iter-
ations made it possible to identify the strengths of each
of the tools but also their weaknesses in order to address
them before evaluating their acceptability by the PVS
along with the expressiveness of their results. The per-
ceived usefulness of the three kinds of tools depends on
the complexity of the MedDRA term search to perform.
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